Standout Papers

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease 2011 2026 2016 2021 787
  1. Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease (2011)
    John Koreth, Ken‐ichi Matsuoka et al. New England Journal of Medicine
  2. Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation (2014)
    Philippe Armand, Haesook T. Kim et al. Blood
  3. Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes (2017)
    Bart L. Scott, Marcelo C. Pasquini et al. Journal of Clinical Oncology

Immediate Impact

17 by Nobel laureates 7 from Science/Nature 58 standout
Sub-graph 1 of 18

Citing Papers

A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
2021 Standout
47 intermediate papers

Works of Edwin P. Alyea being referenced

An Open-Label Phase II Randomized Trial of Topical Dexamethasone and Tacrolimus Solutions for the Treatment of Oral Chronic Graft-versus-Host Disease
2016
Comparison of T-cell–depleted and non–T-cell–depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs
2002
and 35 more

Author Peers

Author Last Decade Papers Cites
Edwin P. Alyea 10431 6668 4077 293 15.4k
Vincent T. Ho 10164 5663 3352 320 14.6k
Corey Cutler 12804 6649 3876 442 17.7k
Todd E. DeFor 9912 6430 5023 293 15.4k
Donna Przepiorka 11882 5531 5392 194 17.9k
Jeff Szer 8108 4587 3384 378 14.7k
A Fefer 9782 5081 3843 159 13.9k
Didier Blaise 11866 4986 4887 644 16.1k
Keith M. Sullivan 10879 4552 3872 234 16.2k
FR Appelbaum 9197 3403 3360 189 12.3k
Marcos de Lima 9003 2821 3438 418 12.4k

All Works

Loading papers...

Rankless by CCL
2026